PHVS
Pharvaris N.V.
$35.07
-0.89 (-2.47%)
At close · Jul 10
Market Cap
$2.37B
Shares
69,879,726
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$35.07
Open$35.79
Day$33.97–36.25
52W$18.10–36.60
Avg vol 30d509K
Short int986K · 1.4% float · 2.3d
Short vol23%
DataFeb 2021–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+29%
above
Price vs 50-day avg
+11%
above
RSI (14)
62
neutral
MACD trend
Positive
52-week position
92%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+11%
trailing
6-month return
+37%
trailing
YTD return
+26%
this year
Relative strength
+28%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $32 › 200d $27 — 50d above 200d
Institutional flow
Distributing
2 of 111 funds reported for Jun 30 · net -2.3K sh shares · +1 new
Insider flow
Distributing
Net -$6.4M over 90 days · 100% sells
Short interest
Falling
1.41% of float · ▼ -12.0% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
111 holders — near 3-yr high, broad support
Squeeze score
50
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
63%
annualized · 1-yr
Max drawdown
−22%
past year
ATR
4.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+29%
Bullish
Price vs 50-day avg
+11%
Bullish
RSI (14)
62
Neutral
MACD trend
Positive
Bullish
52-week position
92%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $32 › 200d $27 — 50d above 200d
Institutional flow
Distributing
2 of 111 funds reported for Jun 30 · net -2.3K sh shares · +1 new
Insider flow
Distributing
Net -$6.4M over 90 days · 100% sells
Short interest
Falling
1.41% of float · ▼ -12.0% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
111 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $18
Now $35 · 92%
52-wk high $37
vs 200-day avg +29%
vs 50-day avg +11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PHVS
this stock
Pharvaris N.V.
|
$2.37B | +26.4% | — | — | 1.4% |
|
ONC
BeOne Medicines Ltd.
|
$431.70B | -1.7% | +22179.2% | 878.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +7.1% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.63B | -13.8% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.85B | +4.4% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PHVS | +3.6% | +11.1% | +36.7% | +1.4% | +26.4% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | +2.2% | +7.1% | +27.7% | +0.3% | +15.7% |